ZAZA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 17.452
AS - Asia 8.304
EU - Europa 7.639
SA - Sud America 1.082
Continente sconosciuto - Info sul continente non disponibili 707
AF - Africa 182
OC - Oceania 28
Totale 35.394
Nazione #
US - Stati Uniti d'America 16.481
SG - Singapore 2.807
IT - Italia 2.274
CN - Cina 1.782
VN - Vietnam 1.625
DE - Germania 1.137
HK - Hong Kong 814
RU - Federazione Russa 806
BR - Brasile 788
CA - Canada 704
SE - Svezia 665
GB - Regno Unito 445
IE - Irlanda 439
PL - Polonia 393
FR - Francia 381
UA - Ucraina 364
IN - India 236
BD - Bangladesh 212
FI - Finlandia 150
KR - Corea 129
AT - Austria 114
NL - Olanda 112
AR - Argentina 107
TR - Turchia 104
MX - Messico 89
ID - Indonesia 88
JP - Giappone 79
IQ - Iraq 78
ES - Italia 77
ZA - Sudafrica 66
DK - Danimarca 63
CH - Svizzera 55
EC - Ecuador 54
CO - Colombia 46
PK - Pakistan 46
PH - Filippine 45
VE - Venezuela 34
UZ - Uzbekistan 33
SA - Arabia Saudita 32
BE - Belgio 31
CR - Costa Rica 29
AU - Australia 25
BG - Bulgaria 25
MY - Malesia 24
SV - El Salvador 23
JM - Giamaica 22
MA - Marocco 20
TH - Thailandia 20
HN - Honduras 19
CL - Cile 17
GT - Guatemala 17
EG - Egitto 16
JO - Giordania 15
LT - Lituania 15
TW - Taiwan 15
PR - Porto Rico 14
IL - Israele 13
KE - Kenya 13
PY - Paraguay 13
TN - Tunisia 13
SC - Seychelles 12
DO - Repubblica Dominicana 11
IR - Iran 11
OM - Oman 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
ET - Etiopia 10
GR - Grecia 10
PT - Portogallo 10
TT - Trinidad e Tobago 10
DZ - Algeria 9
KZ - Kazakistan 9
LB - Libano 9
NP - Nepal 9
RO - Romania 9
CW - ???statistics.table.value.countryCode.CW??? 8
EU - Europa 8
LV - Lettonia 8
NI - Nicaragua 8
RS - Serbia 8
NO - Norvegia 7
AZ - Azerbaigian 6
EE - Estonia 6
GP - Guadalupe 6
PE - Perù 6
SY - Repubblica araba siriana 6
AL - Albania 5
BH - Bahrain 5
BO - Bolivia 5
BY - Bielorussia 5
GE - Georgia 5
MD - Moldavia 5
PA - Panama 5
AM - Armenia 4
AO - Angola 4
BB - Barbados 4
CZ - Repubblica Ceca 4
PS - Palestinian Territory 4
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
Totale 34.642
Città #
Ashburn 1.810
Ann Arbor 1.639
Singapore 1.572
San Jose 1.036
Woodbridge 846
Wilmington 809
Hong Kong 790
Milan 702
Fairfield 680
Frankfurt am Main 560
Council Bluffs 556
Houston 544
Chandler 482
Ho Chi Minh City 452
Dublin 425
Toronto 366
Jacksonville 359
Santa Clara 354
New York 351
Kraków 343
Seattle 334
Hanoi 324
Dallas 302
Dearborn 277
Los Angeles 277
Cambridge 259
Beijing 240
Chicago 216
Hefei 213
The Dalles 165
Princeton 159
Rome 139
Columbus 126
Seoul 125
Dong Ket 120
Nanjing 115
Boardman 114
Buffalo 110
Shanghai 109
Lauterbourg 95
Vienna 94
São Paulo 92
Moscow 78
Lawrence 69
Altamura 68
Helsinki 62
Montreal 60
Lachine 57
Haiphong 56
Jakarta 55
Montréal 55
Phoenix 55
Orem 54
Da Nang 52
Tokyo 48
Atlanta 45
Nanchang 45
Boston 43
Philadelphia 43
Warsaw 43
London 42
Denver 41
Munich 40
San Diego 40
Guangzhou 39
Shenyang 39
Turin 39
Brooklyn 38
Jinan 38
Washington 38
North Bergen 37
Zurich 37
Figino 36
Changsha 35
Florence 35
Miami 34
Torino 34
Rio de Janeiro 33
Baghdad 29
Brussels 29
Stockholm 29
Tianjin 29
Fremont 28
Quận Bình Thạnh 28
Tashkent 28
Chennai 27
Naples 27
Ottawa 27
Sesto San Giovanni 27
Pune 26
Andover 25
Charlotte 25
Hyderabad 24
Johannesburg 24
Ninh Bình 24
San José 24
Quito 23
Amsterdam 22
Biên Hòa 22
Bologna 22
Totale 20.913
Nome #
Early consequences of the phospholamban mutation PLN-R14del+/- in a transgenic mouse model 811
Early consequences of the phospholamban mutation PLN-R14del+/− in a transgenic mouse model 551
Late sodium current and intracellular ionic homeostasis in acute ischemia 536
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 532
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 515
Action Potential Prolongation, β - Adrenergic Stimulation, and Angiotensin II as Co-factors in Sarcoplasmic Reticulum Instability 510
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 497
Action potential contour contributes to species differences in repolarization response to b-adrenergic stimulation 493
Reverse rate dependency is an intrinsic property of canine cardiac preparations 485
Marine n-3 PUFAs modulate IKs gating, channel expression, and location in membrane microdomains 481
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 456
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function 455
Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension 447
Prevention of myocardial remodeling by chronic INaL blockade in pulmonary hypertension 430
CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation 428
Caffeine-induced Ca(2+) signaling as an index of cardiac progenitor cells differentiation 423
Late sodium current (INaL) in pancreatic β-cells 418
Calcium store stability as an antiarrhythmic endpoint 414
Altered functional differentiation of mesoangioblasts in a genetic myopathy 411
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure 402
A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization 393
Blood microsampling for untargeted metabolomics: a preliminary study on patients affected by myocardial infarction 386
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes 385
IKr Impact on Repolarization and Its Variability Assessed by Dynamic Clamp 378
Induced pluripotent stem cells: progress towards a biomedical application 377
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 376
SERCA2a gain of function in patient-derived R14Del hiPSC-CMs 370
Modulation of sarcoplasmic reticulum function by istaroxime (PST2744) in a pressure-overload heart failure model 366
Role and mechanism of subcellular Ca2+ distribution in the action of two inotropic agents with different toxicity 366
Aberrant Functional Differentiation of Cardiac Precursors from a Dystrophic Mouse 365
Peptidomimetic Targeting of Cavβ2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function 356
Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride]. 353
Optimizing blood microsampling protocols for metabolomics and lipidomics: Application in a rehabilitomics study 349
Interstitial pressure and lung oedema in chronic hypoxia 348
Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation 348
Straightforward synthesis of novel Akt inhibitors based on a glucose scaffold 344
Role of the β3-adrenergic receptor subtype in catecholamine-induced myocardial remodeling 336
miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors 333
Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels. Effects on cardiac action potentials 331
A variant in the carboxyl-terminus of connexin 40 alters GAP junctions and increases risk for tetralogy of Fallot 330
Modulation of sympathetic activity and heart rate variability by ivabradine 329
Rate dependency of beta-adrenergic modulation of repolarizing currents in the guinea-pig ventricle 326
Determinants of beat-to-beat variability of repolarization duration in the canine ventricular myocyte: a computational analysis 325
Combined action potential- and dynamic-clamp for accurate computational modelling of the cardiac IKr current 314
Mechanism of reverse rate-dependent action of cardioactive agents 306
Pathophysiology and pharmacology of the cardiac "late sodium current" 305
Istaroxime metabolite PST3093 selectively stimulates SERCA2a and reverses disease-induced changes in cardiac function 302
Characterization of the pln p.Arg14del mutation in human induced pluripotent stem cell-derived cardiomyocytes 298
The role of the autonomic system in rate-dependent repolarization changes 293
Different effects of antiarrhythmic drugs on the rate-dependency of QT interval: a study with amiodarone and flecainide. 292
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment 291
Kinematics but not kinetics alterations to single-leg drop jump movements following a subject-tailored fatiguing protocol suggest an increased risk of ACL injury 287
Selective SERCA2a activator as a candidate for chronic heart failure therapy 285
The late Na+ current--origin and pathophysiological relevance 284
Metabolic adaptations to cardiac rehabilitation through physical exercise: Insights from untargeted metabolomics using dried blood spots in post-myocardial infarction patients 283
Cellular electrophysiology 283
2019 ESC Guidelines for themanagement of patients with supraventricular tachycardia 283
Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744) 282
Ranolazine ameliorates postresuscitation electrical instability and myocardial dysfunction and improves survival with good neurologic recovery in a rat model of cardiac arrest 282
Control of the cardiac action potential: The role of repolarization dynamics 281
Fisiologia normale e patologia dell'atrio 275
Repolarization instability and arrhythmia by IKr block in single human-induced pluripotent stem cell-derived cardiomyocytes and 2D monolayers 272
Theoretical investigation of action potential duration dependence on extracellular Ca2+ in human cardiomyocytes 271
Diverse toxicity associated with cardiac Na+/K+ pump inhibition: Evaluation of electrophysiological mechanisms 270
Special issue on biopacemaking: clinically attractive, scientifically a challenge 266
Mechanisms of beta-adrenergic modulation of I(Ks) in the guinea-pig ventricle: insights from experimental and model-based analysis 259
Self-augmentation of the lengthening of repolarization is related to the shape of the cardiac action potential: Implications for reverse rate dependency 259
Blood microsampling for untargeted metabolomics: a preliminary study on patients affected by myocardial infarction 257
Regulation of the sinoatrial pacemaker. Selective If inhibition by ivabradine 251
Unveiling the biophysical mechanism of cardiomyocyte excitation-contraction coupling modulation by a membrane-targeted photoswitch 246
The long-lasting istaroxime metabolite PST3093 stimulates SERCA2a and reverses disease-induced changes in cardiac function 245
Cardiac precursors in human bone marrow and cord blood: In vitro cell cardiogenesis 245
Serum potassium and arrhythmias 244
Il controllo della frequenza cardiaca e ruolo dei canali f 243
Exercise-induced metabolic changes of cardiac rehabilitation after acute myocardial infarction: Insights from dried blood spot profiling 238
Case of polymorphic ventricular tachycardia after stroke necessitating defibrillation 235
Geneless optomodulation of cardiomyocytes membrane potential by sarcolemma-targeted azobenzene photoswitches 232
Computational cardiac electrophysiology is ready for prime time 230
Exploring the pathophysiological role of the PLN-R14del mutation in a novel heterozygous mouse model of dilated cardiomyopathy 229
Sistema e Funzioni Cardiovascolari 228
Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations 225
Opportunities and challenges of current electrophysiology research: A plea to establish 'translational electrophysiology' curricula 223
Phosphodiesterase 5: A Novel Therapeutic Target in Long QT Syndrome 222
Case of the month by the EHRA Education committee: exercise-related arrhythmias 220
RvD1 and LXA4 inhibitory effects on cardiac voltage-gated potassium channels 219
Deranged sodium to sudden death 218
Computational cardiac electrophysiology is moving towards translation medicine 216
Pre-analytic assessment of blood microsampling for metabolomics and lipidomics. Application in a rehabilitomics study 205
Role of stretch-activated channels in light-generated action potentials mediated by an intramembrane molecular photoswitch 204
Modulation of Ca2+ handling by combinatorial administration of Istaroxime and Levosimendan in mouse ventricular cardiomyocytes 201
Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodelling 196
UNVEILING THE BIOPHYSICAL MECHANISM OF CARDIOMYOCYTE EXCITATION-CONTRACTION COUPLING MODULATION BY A MEMBRANE-TARGETED PHOTOSWITCH 193
Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 2 192
Mechanisms of Cav3-associated arrhythmia: Protein or microdomain dysfunction? 192
Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2 189
Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes Carrying CALM1-F142l Mutation Recapitulate LQTS Phenotype in Vitro 187
Investigating the mechanism of cardiac cell excitability modulation by a membrane-targeted photoswitch 183
Geneless optomodulation of cardiomyocytes membrane potential by membrane-targeted azobenzene photoswitches 178
Rehabilitomics: metabolic effect of cardiac rehabilitation after acute myocardial infarction 174
Sarcolemma-targeted phototransducers for geneless optomodulation of cardiac excitable cells 169
Totale 31.817
Categoria #
all - tutte 102.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022946 0 0 0 0 65 122 78 96 77 140 110 258
2022/20232.239 276 656 248 172 172 290 28 115 132 46 65 39
2023/20241.624 62 48 79 80 164 387 303 130 118 44 43 166
2024/20254.380 181 418 352 189 384 210 249 193 349 654 447 754
2025/202612.423 1.595 906 777 1.339 1.294 627 1.560 539 1.054 1.047 796 889
2026/20274.492 734 659 1.254 1.763 82 0 0 0 0 0 0 0
Totale 35.394